Close

Research Insight

Landmark study confirms complexity and informs the next stages of research

The largest population genome sequencing effort to date is published today in Nature. A series of papers describing resources and application of the data...

Amgen and Kite Pharma to develop CAR T cell immunotherapies

US-based Amgen has signed a strategic research collaboration and license agreement with Kite Pharma to develop and commercialise chimeric antigen receptor (CAR) T cell...

TxCell and Ferring partner with Trizell to further develop Ovasave to treat IBD

France-based TxCell and Switzerland's Ferring International have partnered with Trizell Holding to further enhance the development of TxCell's Ovasave to treat inflammatory bowel diseases...

Novartis, Intellia and Caribou to develop new medicines and drug discovery tools

Swiss drug-maker Novartis has entered collaboration and licensing agreements with Intellia Therapeutics to develop new medicines using CRISPR genome editing technology and Caribou Biosciences...

New technology may detect nucleic acid biomarkers of cancer

A new technique has been developed utilizing nanotechnology to detect disease biomarkers in the form of nucleic acids.The proof-of-concept study came from a team...

UK Medical Research Council scientists create world’s first synthetic enzymes

Scientists at the UK's Medical Research Council (MRC) have created the world's first enzymes made from artificial genetic material, which are capable...

Hilleman signs MoU with Bangladesh firms to develop oral cholera vaccine

Hilleman Laboratories, a joint venture of Merck and Wellcome Trust, has signed a memorandum of understanding (MoU) with Bangladesh-based icddr,b and Incepta Vaccine to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read